(Q35125721)

English

Positive HER-2 protein expression in circulating prostate cells and micro-metastasis, resistant to androgen blockage but not diethylstilbestrol

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Positive HER-2 protein expression in circulating prostate cells and micro-metastasis, resistant to androgen blockage but not diethylstilbestrol (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

Nigel P Murray

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Leonardo V Badinez

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Ricardo R Dueñas

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Nelson Orellana

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Pablo Tapia

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Indian Journal of Urology

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

200-207

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3142830

28 July 2018

Bicalutamide demonstrates biologic effectiveness in prostate cancer cell lines and tumor primary cultures irrespective of Her2/neu expression levels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3142830

28 July 2018

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3142830

28 July 2018

Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3142830

28 July 2018

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3142830

28 July 2018

Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3142830

28 July 2018

Presence of prostate cells in bone marrow biopsies as a sign of micrometastasis in cancer patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3142830

27 September 2018

Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3142830

27 September 2018

Efficacy and safety of single-agent pertuzumab (rhuMAb 2C4), a human epidermal growth factor receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3142830

27 September 2018

Mechanisms of androgen-refractory prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3142830

27 September 2018

The use of trastuzumab in the treatment of hormone refractory prostate cancer; phase II trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3142830

27 September 2018

The role of diethylstilbestrol in the treatment of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3142830

27 September 2018

Frequent loss of estrogen receptor-beta expression in prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3142830

27 September 2018

Her-2-neu expression and progression toward androgen independence in human prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3142830

27 September 2018

Pretreatment serum level of HER2/nue as a prognostic factor in metastatic prostate cancer patients about to undergo endocrine therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21814310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2/neu (p185neu) protein expression in the natural or treated history of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21814310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21814310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and -independent human xenograft models

1 reference

https://pubmed.ncbi.nlm.nih.gov/21814310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunocytochemical monitoring of micrometastatic disease: reduction of prostate cancer cells in bone marrow by androgen deprivation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21814310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4103/0970-1591.82838

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35125721&oldid=1975618514"